These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 2491470)
1. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects. Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470 [TBL] [Abstract][Full Text] [Related]
2. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer. Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G Digestion; 1987; 37(2):103-9. PubMed ID: 3305114 [TBL] [Abstract][Full Text] [Related]
3. Effect of oral famotidine on 24-hour intragastric acidity. Santana IA; Lanzon-Miller S; Pounder RE Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150 [TBL] [Abstract][Full Text] [Related]
4. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer. Gledhill T; Howard OM; Buck M; Paul A; Hunt RH Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692 [TBL] [Abstract][Full Text] [Related]
5. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine. Hamilton MI; Sercombe J; Pounder RE Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997 [TBL] [Abstract][Full Text] [Related]
6. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine. Fullarton GM; Macdonald AM; McColl KE Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675 [TBL] [Abstract][Full Text] [Related]
7. Twenty-four-hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily. Howden CW; Tsai HH; Reid JL Aliment Pharmacol Ther; 1989 Jun; 3(3):253-8. PubMed ID: 2520620 [TBL] [Abstract][Full Text] [Related]
8. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients? Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218 [TBL] [Abstract][Full Text] [Related]
9. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167 [TBL] [Abstract][Full Text] [Related]
10. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease. Thomson AB Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583 [TBL] [Abstract][Full Text] [Related]
11. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs. Savarino V Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412 [TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Lanzon-Miller S; Pounder RE; Hamilton MR; Ball S; Chronos NA; Raymond F; Olausson M; Cederberg C Aliment Pharmacol Ther; 1987 Jun; 1(3):239-51. PubMed ID: 2979226 [TBL] [Abstract][Full Text] [Related]
13. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease. Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938 [TBL] [Abstract][Full Text] [Related]
14. Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients. Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Kaufmann D; Mappes A; Heim J; Röhmel J Aliment Pharmacol Ther; 1987 Jun; 1(3):217-23. PubMed ID: 2979224 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G Digestion; 1989; 42(1):1-6. PubMed ID: 2568299 [TBL] [Abstract][Full Text] [Related]
16. A prospective comparison of the effects of placebo, ranitidine and highly selective vagotomy on 24 h ambulatory intragastric pH in patients with duodenal ulcer. Rogers MJ; Holmfield JH; Primrose JN; Gledhill T; Johnston D Br J Surg; 1988 Oct; 75(10):961-5. PubMed ID: 3219542 [TBL] [Abstract][Full Text] [Related]
17. The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects. Lanzon-Miller S; Pounder RE; Ball SG; Dalgleish DJ; Coward J; Jackson AO Scand J Gastroenterol; 1988 Mar; 23(2):244-50. PubMed ID: 3283919 [TBL] [Abstract][Full Text] [Related]
18. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man. Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of two cimetidine regimens on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer. Mahachai V; Walker K; Jamali F; Navert H; Cook D; Symes A; Thomson AB Clin Ther; 1984; 6(3):259-81. PubMed ID: 6373006 [TBL] [Abstract][Full Text] [Related]
20. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo. Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]